Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo

• Published in: Nature communications Vol. 12; no. 1; p. 3210
• Main Authors: Zekonyte, Ugne, Bacman, Sandra R., Smith, Jeff, Shoop, Wendy, Pereira, Claudia V., Tomberlin, Ginger, Stewart, James, Jantz, Derek, Moraes, Carlos T.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 28.05.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 13; 13/1; 13/106; 42/44; 631/337/1427/2122; 631/61/201; 64; 64/60; 692/4017; Deoxyribonucleic acid; DNA; Gene therapy; Genetic modification; Genome editing; Heteroplasmy; Humanities and Social Sciences; Mitochondria; Mitochondrial DNA; multidisciplinary; Muscles; Mutants; Mutation; Reagents; Science; Science (multidisciplinary); Skeletal muscle
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-021-23561-7

Diseases caused by heteroplasmic mitochondrial DNA mutations have no effective treatment or cure. In recent years, DNA editing enzymes were tested as tools to eliminate mutant mtDNA in heteroplasmic cells and tissues. Mitochondrial-targeted restriction endonucleases, ZFNs, and TALENs have been successful in shifting mtDNA heteroplasmy, but they all have drawbacks as gene therapy reagents, including: large size, heterodimeric nature, inability to distinguish single base changes, or low flexibility and effectiveness. Here we report the adaptation of a gene editing platform based on the I-CreI meganuclease known as ARCUS ® . These mitochondrial-targeted meganucleases (mitoARCUS) have a relatively small size, are monomeric, and can recognize sequences differing by as little as one base pair. We show the development of a mitoARCUS specific for the mouse m.5024C>T mutation in the mt-tRNA Ala gene and its delivery to mice intravenously using AAV9 as a vector. Liver and skeletal muscle show robust elimination of mutant mtDNA with concomitant restoration of mt-tRNA Ala levels. We conclude that mitoARCUS is a potential powerful tool for the elimination of mutant mtDNA. Heteroplasmic mitochondrial DNA mutations lack effective treatments. Here the authors adapt I-CreI meganuclease to target the mitochondria and specifically-eliminate mtDNA with a m.5024C>T mutation in the mttRNA Ala gene.